Skip to content
10-Q

Quarterly Report

Climb Bio, Inc. CLYM

0001193125-25-268086

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 68.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 67.69M sh
Shares Diluted Q3 2025 · Sep 30, 2024 67.01M sh
Shares Diluted Q3 2025 · Sep 30, 2024 41.76M sh
Capex Q3 2025 · Sep 30, 2025 $186K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$38.72M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$10.04M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $25.8M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $87.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 $177M
Stockholders Equity Q3 2025 · Jun 30, 2025 $185.76M
Stockholders Equity Q3 2025 · Mar 31, 2025 $193.39M
Stockholders Equity Q3 2025 · Dec 31, 2024 $211.88M
Stockholders Equity Q3 2025 · Sep 30, 2024 $218.78M
Stockholders Equity Q3 2025 · Jun 30, 2024 $222.28M
Stockholders Equity Q3 2025 · Mar 31, 2024 $106.38M
Stockholders Equity Q3 2025 · Dec 31, 2023 $107.6M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.95M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.93M
Total Liabilities Q3 2025 · Sep 30, 2025 $5.3M
Total Liabilities Q3 2025 · Dec 31, 2024 $5.31M
Current Assets Q3 2025 · Sep 30, 2025 $90.96M
Current Assets Q3 2025 · Dec 31, 2024 $154.87M
Total Assets Q3 2025 · Sep 30, 2025 $182.3M
Total Assets Q3 2025 · Dec 31, 2024 $217.19M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.19
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.63
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.57
Eps Basic Q3 2025 · Sep 30, 2025 −$0.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.63
Eps Basic Q3 2025 · Sep 30, 2024 −$0.13
Eps Basic Q3 2025 · Sep 30, 2024 −$1.57
Sga Expense Q3 2025 · Sep 30, 2025 $5.82M
Sga Expense Q3 2025 · Sep 30, 2025 $15.61M
Sga Expense Q3 2025 · Sep 30, 2024 $5.49M
Sga Expense Q3 2025 · Sep 30, 2024 $11.07M
Rd Expense Q3 2025 · Sep 30, 2025 $9.07M
Rd Expense Q3 2025 · Sep 30, 2025 $32.98M
Rd Expense restated Q3 2025 · Sep 30, 2024 $6.24M
Rd Expense restated Q3 2025 · Sep 30, 2024 $8.38M
Net Income Q3 2025 · Sep 30, 2025 −$12.89M
Net Income Q3 2025 · Sep 30, 2025 −$42.34M
Net Income Q3 2025 · Jun 30, 2025 −$8.67M
Net Income Q3 2025 · Mar 31, 2025 −$20.78M
Net Income Q3 2025 · Sep 30, 2024 −$8.9M
Net Income Q3 2025 · Sep 30, 2024 −$65.48M
Net Income Q3 2025 · Jun 30, 2024 −$54.89M
Net Income Q3 2025 · Mar 31, 2024 −$1.7M
Operating Income Q3 2025 · Sep 30, 2025 −$14.89M
Operating Income Q3 2025 · Sep 30, 2025 −$48.59M
Operating Income Q3 2025 · Sep 30, 2024 −$11.73M
Operating Income Q3 2025 · Sep 30, 2024 −$71.11M